Prayat Shah is the current VP – Enterprise Partnerships at Wellthy Therapeutics. Prayat has over 10 years of experience in management consulting and the pharmaceutical industry.
Shah began their career as a management consultant with KPMG in May 2014. Prayat worked with clients in the pharmaceutical and life sciences industries, providing strategic and operational advice. In October 2015, Shah left KPMG to join Wellthy Therapeutics.
Prior to KPMG, Shah worked as a client solutions executive with Nielsen, a global marketing research firm. Prayat helped clients in the pharmaceutical and life sciences industries customize research solutions to meet their needs. Shah left Nielsen in April 2013 to join Wellthy Therapeutics.
Before joining Nielsen, Shah was a part of PwC Consulting’s India Pharma & Life Sciences practice. Prayat worked on projects such as organizing the “CII-Pharma Summit 2010”, an international conference attended by CEO’s and MD’s of Indian and multinational Pharma companies. Shah also co-authored the Thought Leadership report “India Pharma Inc.: Capitalising on India’s Growth Potential”, which provided comprehensive growth predictions for key segments of the Indian pharmaceutical market. Shah left PwC Consulting in September 2010 to join Nielsen.
Shah has also interned with Johnson & Johnson Medical and Connexios Life Sciences (P) Ltd.
Prayat Shah has a Master of Business Administration (M.B.A.) from the Indian School of Business and a B.Sc. (Hons.) in Biological Sciences from Nanyang Technological University Singapore.
A direct report to Prayat Shah is and Anshul Srivastava - AVP – Account Management. Prayat Shah works with Harish More - AVP, Care Delivery, Mugdha K Mhadeshwar - VP - Finance, and Pratik Patil - Manager Strategy. Prayat Shah reports to Abhishek Shah, CEO.
View in org chart
View in org chart